Sex disparities in thyroid cancer may need further exploration
Letter to the Editor

Sex disparities in thyroid cancer may need further exploration

Jun Zhou

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Correspondence to: Jun Zhou. Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Email: doctorzhoujun@163.com.

Comment on: Li P, Ding Y, Liu M, et al. Sex disparities in thyroid cancer: a SEER population study. Gland Surg 2021;10:3200-10.


Keywords: Sex; Surveillance, Epidemiology, and End Results (SEER); thyroid cancer


Submitted Jan 21, 2023. Accepted for publication Mar 21, 2023. Published online Apr 04, 2023.

doi: 10.21037/gs-23-28


The prognosis of most thyroid cancer patients is usually excellent, but sex differences in the prognosis of thyroid cancer remain controversial. Li et al. recently reported an article (1) and I congratulate the authors for making a sincere attempt at this topic assessing sex disparities in thyroid cancer. However, there are certain caveats to this interpretation.

First, the thyroid gland is a relatively superficial organ, and the size of thyroid tumors is generally not too large. The mean tumor size in many studies (2-4) that analyzed thyroid cancer using the Surveillance, Epidemiology, and End Results (SEER) database was generally around 20 millimeters, while the mean sizes in the article by Li et al. (1) were 17.4 centimeters in females and 23.5 centimeters in males, respectively, and there is a significant difference between their study and clinical practice and other studies. The reason for this discrepancy may be that the authors miscalculated the units of tumor size. Double-check their data and relevant modifications are suggested.

Second, a major change in the American Joint Committee on Cancer (AJCC) staging manual, eighth edition, for differentiated and anaplastic thyroid carcinoma, is that the age cut-off was adjusted to 55 years from 45 years in the seventh edition (5). In their study, they used the age cut-off of 55 years from the eighth edition of AJCC staging system, but other staging criteria were from the seventh edition, which might lead to certain unpredictable biases. It is recommended to use the same AJCC staging system in the same study. While their article was published in 2021, and the eighth edition has been proposed in 2016, it is possible to use the latest AJCC staging system to make the study more consistent with the current research background.

In summary, I am enthusiastic about the study proposed by the authors and the study opened up new ideas for the sex disparities in thyroid cancer. However, some imperfections of the study also need to be addressed, and this may help the authors and readers understand the subject better. Sex disparities in thyroid cancer may still need further exploration.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was a standard submission to the journal. The article did not undergo external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-23-28/coif). The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Li P, Ding Y, Liu M, et al. Sex disparities in thyroid cancer: a SEER population study. Gland Surg 2021;10:3200-10. [Crossref] [PubMed]
  2. Liu Z, Chen S, Huang Y, et al. Synergic effects of histology subtype, tumor size, and lymph node metastasis on distant metastasis in differentiated thyroid cancer. Ann Transl Med 2019;7:533. [Crossref] [PubMed]
  3. Zhang K, Su A, Wang X, et al. Non-Linear Correlation Between Tumor Size and Survival Outcomes for Parathyroid Carcinoma: A SEER Population-Based Cohort Study. Front Endocrinol (Lausanne) 2022;13:882579. [Crossref] [PubMed]
  4. Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol 2013;31:468-74. [Crossref] [PubMed]
  5. Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2018;68:55-63.
Cite this article as: Zhou J. Sex disparities in thyroid cancer may need further exploration. Gland Surg 2023;12(4):562-563. doi: 10.21037/gs-23-28

Download Citation